T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii

Microbes and Infection

Volumn 1, Issue 9, 1999, Pages 699-708

  Denkers, Eric Y ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cytokine; Interferon gamma; Nitric oxide; T lymphocyte; Toxoplasma

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; HOST PARASITE INTERACTION; HUMAN; INFLAMMATION; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA; TOXOPLASMA GONDII;

PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 0032718790     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80071-9     Document Type: Review

References (85)

1. Zenner L., Darcy F., Capron A., Cesbron-Delauw M.F. Toxoplasma gondii: kinetics of the dissemination in the host tissues during the acute phase of infection of mice and rats. Exp. Parasitol. 90:1998;86-94.
2. Denkers E.Y., Marshall A.J. Neutrophils as a source of immunoregulatory cytokines during microbial infection. The Immunologist. 6:1998;116-120.
3. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:1994;2533-2543.
4. Reis E Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. M. 186:1997;1819-1829.
5. Scharton-Kersten T.M., Wynn T.A., Denkers E.Y., Bala S., Showe L., Grunvald E., Hieny S., Gazzinelli R.T., Sher A. In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:1996;4045-4054.
6. Denkers E.Y., Scharton-Kersten T., Gazzinelli R.T., Yap G., Charest H., Sher A. Cell-mediated immunity to Toxoplasma gondii: Redundant and required mechanisms as revealed by studies in gene knockout mice. Kaufmann S.H.E. Medical Intelligence Unit: Host Response to Intracellular Pathogens. 1997;167-181 R.G. Landes Company, Austin.
7. Denkers E.Y., Gazzinelli R.T. Regulation and function of T cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:1998;569-588.
8. Alexander J., Hunter C.A. Immunoregulation during toxoplasmosis. Chem. Immunol. 70:1998;81-102.
9. Scharton-Kersten T., Denkers E.Y., Gazzinelli R.T., Sher A. Role of IL-12 in the induction of cell-mediated immunity to Toxoplasma gondii. Res. Immunol. 146:1995;539-545.
10. Guo Z.G., Johnson A.M. DNA polymorphisms associated with murine virulence of Toxoplasma gondii identified by RAPD-PCR. Curr. Top. Microbiol. Immunol. 216:1996;17-26.
11. Sibley L.D., Howe D.K. Genetic basis of pathogenicity in toxoplasmosis. Curr. Top. Microbiol. Immunol. 216:1996;4-15.
12. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 359:1992;82-85.
13. Darde M.L. Biodiversity in Toxoplasma gondii. Curr. Top. Microbiol. Immunol. 216:1996;27-41.
14. Suzuki Y., Conley F.K., Remington J.S. Differences in virulence and development of encephalitis during chronic infection vary with strain of Toxoplasma gondii. J. Infect. Dis. 790:1989;790-794.
15. Suzuki Y., Joh K. Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma. Parasitol. Res. 80:1994;125-130.
16. Pfefferkorn E.R., Pfefferkorn L.C. Toxoplasma gondii: Isolation and preliminary characterization of temperature-sensitive mutants. Exp. Parasitol. 39:1976;365-376.
17. Waldeland H., Pfefferkorn E.R., Frenkel J.K. Temperature-sensitive mutants of Toxoplasma gondii: pathogenicity and persistence in mice. J. Parasitol. 69:1983;171-175.
18. Sayles P.C., Johnson L.L. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii. Infect. Immun. 64:1996;3088-3092.
19. McLeod R., Brown C., Mack D. Immunogenetics influence outcome of Toxoplasma gondii infection. Res. Immunol. 144:1993;61-65.
20. Denkers E.Y., Gazzinelli R.T., Hieny S., Caspar P., Sher A. Bone marrow macrophages process exogenous Toxoplasma gondii peptides for recognition by parasite-specific cytolytic T lymphocytes. J. Immunol. 150:1993;517-526.
21. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:1991;2310-2316.
22. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:1991;3955-3959.
23. + T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J. Immunol. 148:1992;1493-1498.
24. + T cells in mice. J. Immunol. 140:1988;3943-3946.
25. + immune T cells against toxoplasmosis in mice. J. Immunol. 144:1990;1954-1956.
26. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated T. gondii vaccine. J. Immunol. 146:1991;286-292.
27. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:1992;175-180.
28. Suzuki Y., Conley F.K., Remington J.S. Importance of endogenous IFN-γ for the prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:1989;2045-2050.
29. Hunter C.A., Subauste C.S., VanCleave V.H., Remington J.S. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10 interleukin-12 and tumor necrosis factor alpha. Infect. Immun. 62:1994;2818-2824.
30. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152:1994;1856-1860.
31. + cells as effectors of immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. M. 178:1993;1465-1472.
32. Su H.C., Orange J.S., Fast L.D., Chan A.T., Simpson S.J., Terhorst C., Biron C.A. IL-2-dependent NK cell responses discovered in virus-infected β2-microglobulin-deficient mice. J. Immunol. 153:1994;5674-5681.
33. + effector function against intracellular infection. J. Exp. M. 184:1996;131-139.
34. + T cells in regulating cell-mediated immunity during Toxoplasma gondii infection. Biochem. Soc. Trans. 25:1997;699-703.
35. Buzoni-Gatel D., Lepage A.C., Dimier-Poisson I.H., Bout D.T., Kasper L.H. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. J. Immunol. 158:1997;5883-5889.
36. Lepage A.C., Buzoni-Gatel D., Bout D.T., Kasper L.H. Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii. J. Immunol. 161:1998;4902-4908.
37. + gut iintraepithelial lymphocytes lytic for parasite-infected enterocytes. J. Immunol. 153:1994;4596-4603.
38. + T-helper cell and a T-killer cell. Nature. 393:1998;474-478.
39. Dubey C., Croft M., Swain S.L. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J. Immunol. 157:1996;3280-3289.
40. Denkers E.Y., Yap G., Scharton-Kersten T., Charest H., Butcher B., Caspar P., Heiny S., Sher A. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1997;1903-1908.
41. Yamashita K., Yui K., Ueda M., Yano A. Cytotoxic T-lymphocyte-mediated lysis of Toxoplasma gondii-infected target cells does not lead to death of intracellular parasites. Infect. Immun. 66:1998;4651-4655.
42. + T lymphocytes in intracellular microbial infections. Immunol. Today. 9:1988;168-174.
43. Suzuki Y., Conley F.K., Remington J.S. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect. Immun. 58:1990;3050-3055.
44. Dimier I.H., Bout D.T. Inhibition of Toxoplasma gondii replication in IFN-gamma-activated intestinal epithelial cells. Immunol. Cell Biol. 75:1997;511-514.
45. Woodman J.P., Dimier I.H., Bout D.T. Human endothelial cells are activated by IFN-gamma to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J. Immunol. 147:1991;2019-2023.
46. Langermans J.A.M., Van der Hulst M.E.B., Nibbereing P.H., Hiemstra P.S., Fransen L., VanFurth R. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α J. Immunol. 148:1992;568-578.
47. Jun C.D., Kim S.H., Soh C.T., Kang S.S., Chung H.T. Nitric oxide mediates the toxoplasmastatic activity of murine microglial cells in vitro. Immunol. Invest. 22:1993;487-501.
48. Chao C.C., Hu S., Gekker G., Novick J.W.J., Remington J.S., Peterson P.K. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 150:1993;3404-3410.
49. Halonen S.K., Chiu F.C., Weiss L.M. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect. Immun. 66:1998;4989-4993.
50. Sibley L.D., Adams L.B., Fukutomi A.Y., Krahenbuhl J.L. Tumor necrosis factor-α triggers antitoxoplasmal activity in IFN-γ primed macrophages. J. Immunol. 147:1991;2340-2345.
51. Nashleanas M., Kanaly S., Scott P. Control of Leishmania major infection in mice lacking TNF receptors. J. Immunol. 160:1998;5506-5513.
52. Yap G.S., Scharton-Kersten T., Charest H., Sher A. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160:1998;1340-1345.
53. Adams L.B., Hibbs J.J.B., Taintor R.R., Krahenbuhl J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:1990;2725-2729.
54. Scharton-Kersten T., Yap G., Magram J., Sher A. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. M. 185:1997;1-13.
55. Khan I.A., Schwartzman J.D., Matsuura T., Kasper L.H. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA. 94:1997;13955-13960.
56. Khan I.A., Matsuura T., Kasper L.H. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161:1998;2994-3000.
57. Beatty W.L., Belanger T.A., Desai A.A., Morrison R.P., Byrnre G.I. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:1994;3705-3711.
58. Pfefferkorn E.R. Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA. 81:1984;908-912.
59. Pfefferkorn E.R., Eckel M., Rebhun S. Interferon-γ suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol. Biochem. Parasitol. 20:1986;215-224.
60. Thomas S.M., Garrity L.F., Brandt C.R., Schobert C.S., Feng G.S., Taylor M.W., Carlin J.M., Byrine G.I. IFN-γ-mediated antimicrobial response. Indolamine 23-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J. Immunol. 150:1993;5529-5534.
61. Gupta S.L., Carlin J.M., Pyati P., Dai W., Pfefferkorn E.R., Murphy JrMj. Antiparasitic and antiproliferative effects of indolamine 23-dioxygenase enzyme expression in human fibroblasts. Infect. Immun. 62:1994;2277-2284.
62. Habara-Ohkubo A., Shirahata T., Takikawa O., Yoshida R. Establishment of an antitoxoplasma state by stable expression of mouse indolamine 23-dioxygenase. Infect. Immun. 61:1993;1810-1813.
63. Mehta S.J., Miller R.D., Ramirez J.A., Summersgill J.T. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism. J. Infect. Dis. 5:1998;1326-1331.
64. Igietseme J.U., Ananaba G.A., Candal D.H., Lyn D., Black C.M. Immune control of Chlamydia growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction tryptophan catabolism and iron deprivation. Microbiol. Immunol. 42:1998;617-625.
65. Schwartzman J.D., Gonias S.L., Pfefferkorn E.R. Murine gamma interferon fails to inhibit Toxoplasma gondii growth in murine fibroblasts. Infect. Immun. 58:1990;833-834.
66. Ding A., Hwang S., Schwab R. Effect of aging on murine macrophages. Diminished response to IFN-gamma for enhanced oxidative metabolism. J. Immunol. 153:1994;2146-2152.
67. Cassatella M.A., Cappelli R., DellaBianca V., Grzeskowiak M., Dusi S., Berton G. Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology. 63:1988;499-506.
68. Gregory S.H., Wing E.J. IFN-gamma inhibits the replication of Listeria monocytogenes in hepatocytes. Infect. Immun. 151:1993;1401-1409.
69. Jackson S.H., Gallin J.I., Holland S.M. The p47phox mouse knockout model of chronic granulomatous disease. J. Exp. M. 182:1995;751-758.
70. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. M. 158:1983;670-689.
71. Bohne W., Heesemann J., Gross U. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect. Immun. 61:1993;1141-1145.
72. Bohne W., Heesemann J., Gros U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 62:1994;1761-1767.
73. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:1995;151-177.
74. + T cells and accompanied by overproduction of IL-12 IFN-γ and TNF-α J. Immunol. 157:1996;798-805.
75. Neyer L.E., Grunig G., Fort M., Remington J.S., Rennick D., Hunter C.A. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65:1997;1675-1682.
76. Roberts C.W., Ferguson D.J.P., Jebbari H., Satoskar A., Bluethmann H., Alexander J. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect. Immun. 64:1996;897-904.
77. Suzuki Y., Yang Q., Yang S., Nguuyen N., Lim S., Leisenfeld O., Kojima T., Remington J. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 157:1996;2564-2569.
78. Jebbari H., Roberts C.W., Ferguson D.J.P., Bluethmann H., Alexander J. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20:1998;231-239.
79. Hunter C.A., Remington J.S. Immunopathogenesis of toxoplasmic encephalitis. J. Infect. Dis. 170:1994;1057-1067.
80. Israelski D.M., Araujo F.G., Conley F.K., Suzuki Y., Sharma S., Remington J.S. Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis. J. Immunol. 142:1989;954-958.
81. Brown C.R., Hunter C.A., Estes R.A., Beckmann E., Forman J., David C., Remington J.S., McLeod R. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology. 85:1995;419-428.
82. Suzuki Y., Wong S.Y., Grumet F.C., Fessel J., Montoya J.G., Zolopa A.R., Portmore A., Schumacher-Perdreau F., Schrappe M., Koppen S., Ruf B., Brown B.W., Remington J.S. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J. Infect. Dis. 173:1996;265-268.
83. + T cell-dependent IFN-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. M. 184:1996;597-607.
84. Liesenfeld O., Kosek J.C., Suzuki Y. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii. Infect. Immun. 65:1997;4682-4689.
85. Marshall A.J., Denkers E.Y. Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-Galactosamine sensitized mice. Infect. Immun. 66:1998;1325-1333.